Expanded Access Program (EAP) for Obecabtagene Autoleucel (obe-cel) Out-of-specification (OOS) in Adult Patients with Acute Lymphoblastic Leukemia

This clinical trial is for adults who have relapsed/refractory acute lymphoblastic leukemia (ALL) and the Obe-Cel product prescribed by their study doctor did not meet commercial release criteria.